| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/29/2005 | US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/29/2005 | US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders |
| 09/29/2005 | US20050214841 Substrate for biochip |
| 09/29/2005 | US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof |
| 09/29/2005 | US20050214835 Diagnosis and treatment of myocardial failure |
| 09/29/2005 | US20050214830 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214824 Nucleic acid probe array comprising sets of probes for interrogating joining sequences between transcriptional units |
| 09/29/2005 | US20050214822 Using cypin in assays, diagnostics and treatment of cognitive disorders |
| 09/29/2005 | US20050214820 Diagnosis of sepsis using mitochondrial nucleic acid assays |
| 09/29/2005 | US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214818 Using cells expressing armitage (ARMI) polypetide as models for id entifying modulators of cell proliferative disorders |
| 09/29/2005 | US20050214817 Proteases from gram-positive organisms |
| 09/29/2005 | US20050214816 Expression vector comprising nucleotide sequences coding serine protease for use as proteolytic agent in cleaning products |
| 09/29/2005 | US20050214813 Amyloid-beta protein aggregation-regulating factors |
| 09/29/2005 | US20050214812 Assay for detecting methylation status by methylation specific primer extension (MSPE) |
| 09/29/2005 | US20050214808 Plant having tolerance to environmental stress |
| 09/29/2005 | US20050214804 Novel human metalloprotease and polynucleotides encoding the same |
| 09/29/2005 | US20050214802 screening inhibitors of caspase interaction with a melanoma-inhibitor of apoptosis (ML-IAP) chimera; diagnosing cancer |
| 09/29/2005 | US20050214799 Device and method for printing biomolecules onto substrate using electrohydrodynamic effect |
| 09/29/2005 | US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents |
| 09/29/2005 | US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome |
| 09/29/2005 | US20050214791 Therappeutic polypeptide for treatment of metabolic disorders |
| 09/29/2005 | US20050214790 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of schizophrenia |
| 09/29/2005 | US20050214784 Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids |
| 09/29/2005 | US20050214782 High throughput screening; ELISA; PCR; blot analysis |
| 09/29/2005 | US20050214780 Using polymorphism in potassium channel interacting protein (KChIP1) as diagnostic indicator for pancreatic disorders |
| 09/29/2005 | US20050214774 Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof |
| 09/29/2005 | US20050214772 Thio modified aptamer synthetic methods and compositions |
| 09/29/2005 | US20050214768 Regulation of human serine/threonine kinase |
| 09/29/2005 | US20050214765 Process for isolating nucleic acid with chaotrope agents and ammonium compounds |
| 09/29/2005 | US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins |
| 09/29/2005 | US20050214761 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids |
| 09/29/2005 | US20050214759 Enzymatic redox labelling of nucleic acids |
| 09/29/2005 | US20050214756 Cell visual characteristic-modifying sequences |
| 09/29/2005 | US20050214754 Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 09/29/2005 | US20050214753 Detection of nucleic acid hybrids |
| 09/29/2005 | US20050214746 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 09/29/2005 | US20050214743 Using reduced binding of viral particle specific antibodies as indicator of individuals with enhanced response to viral infection; viricides |
| 09/29/2005 | US20050214739 Expression of G protein coupled receptors in yeast |
| 09/29/2005 | US20050214738 Animal models comprising rapamycin binding (FRB) domain and target of rapamycin (TOR) sequence for use in identifying modulators of cellular pathways |
| 09/29/2005 | US20050214410 Modified xylanases exhibiting improved expression |
| 09/29/2005 | US20050214357 Phospholipids bilayer and aqueous core, hydrophobic drug, vitamin E derivative, and phosphatidyl choline; sonication; homogenization; increased encapsulation efficiency |
| 09/29/2005 | US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced |
| 09/29/2005 | US20050214323 Modified vaccinia ankara virus variant and cultivation method |
| 09/29/2005 | US20050214321 Recombinant icosahedral virus like particle production in pseudomonads |
| 09/29/2005 | US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus |
| 09/29/2005 | US20050214319 Peptides and DNA encoding peptides that carry novel cytotoxic T lymphocyte epitopes derived from fragments of human immunodeficiency virus-1 Pol or envelope proteins and carry HLA-A*1101 binding motif; vaccines |
| 09/29/2005 | US20050214314 Human cytokine receptor |
| 09/29/2005 | US20050214313 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease |
| 09/29/2005 | US20050214311 Immunocomplex of an antigen, especially a tumor-associated antigen, bacterial or viral antigen, and Fas ligand as an adjuvant; fusion protein; nucleic acid; treating cancer |
| 09/29/2005 | US20050214305 VEGI, an inhibitor of angiogenesis and tumor growth |
| 09/29/2005 | US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214269 Induction of beta cell differentiation in human cells |
| 09/29/2005 | US20050214266 Pretreating hematopoietic stem cells harvested from blood or bone marrow, tissue materials and/or organs prior to surgical implantation; preventing infections |
| 09/29/2005 | US20050214264 Engineered to include recombinant lytic factor; evades host immune system; high capacity, target cell specificity; genes and nonnucleic acid materials |
| 09/29/2005 | US20050214263 Inserting expression cassette having promoter operably linked to chimeric nucleotide sequence encoding all or part of target gene and transgene into organism genome using recombinant DNA construct; initiating post transcriptional gene silencing; plant cells, transgenic plants |
| 09/29/2005 | US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/29/2005 | US20050214258 Vectors for delivering viral and oncogenic inhibitors |
| 09/29/2005 | US20050214256 Expression cassette generated from these sequences; generating an immune response in a subject |
| 09/29/2005 | US20050214254 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine |
| 09/29/2005 | US20050214253 Interferon-beta fusion proteins and uses |
| 09/29/2005 | US20050214252 Chordin-like molecules and uses thereof |
| 09/29/2005 | US20050212837 Processing apparatus which performs predetermined processing while supplying a processing liquid to a substrate |
| 09/29/2005 | US20050211559 Use of microfluidic systems in the electrochemical detection of target analytes |
| 09/29/2005 | DE10350474B4 Verfahren zur Selektion von Biomolekülen aus Varianten-Bibliotheken von Biomolekülen A method of selecting variants of biomolecules from libraries of biomolecules |
| 09/29/2005 | DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 09/29/2005 | DE102004012481A1 Using uridine monophosphate synthase as target for identifying herbicides and plant growth regulators, also the identified compounds and transgenic plants resistant to them |
| 09/29/2005 | CA2815554A1 Irna agents targeting vegf |
| 09/29/2005 | CA2795418A1 Improved bacterial host cell for the direct expression of peptides |
| 09/29/2005 | CA2563345A1 Follicle stimulating hormone superagonists |
| 09/29/2005 | CA2560636A1 Glycosylation variants of ricin-like proteins |
| 09/29/2005 | CA2560581A1 Pluripotent stem cell growing method |
| 09/29/2005 | CA2560551A1 Transgenic model for alzheimer's disease |
| 09/29/2005 | CA2560269A1 Combinatorial methods and compositions for treatment of melanoma |
| 09/29/2005 | CA2560247A1 Thrombin derivative and pharmaceutical composition containing the same |
| 09/29/2005 | CA2560220A1 Genetically modified plants expressing p1b-type atpase of the zn+2/co+2/cd+2/pb+2 subclass and their applications in phytoremediation |
| 09/29/2005 | CA2559955A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 09/29/2005 | CA2559936A1 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 09/29/2005 | CA2559840A1 Prostatic acid phosphatase antigens |
| 09/29/2005 | CA2559768A1 Method of stirring solution |
| 09/29/2005 | CA2559720A1 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 09/29/2005 | CA2559662A1 Novel antibiotic alternatives |
| 09/29/2005 | CA2559586A1 Methods and compositions involving s-ship promoter regions |
| 09/29/2005 | CA2559544A1 C20orf23 as modifier of the igfr pathway and methods of use |
| 09/29/2005 | CA2559543A1 Pdes as modifiers of the igfr pathway and methods of use |
| 09/29/2005 | CA2559436A1 Materials for treating vascular leakage in the eye |
| 09/29/2005 | CA2559361A1 Expression of nitrile hydratases in a two-vector expression system |
| 09/29/2005 | CA2559280A1 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 09/29/2005 | CA2559209A1 Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| 09/29/2005 | CA2559161A1 Irna agents targeting vegf |
| 09/29/2005 | CA2558749A1 Polynucleotide synthesis |
| 09/29/2005 | CA2558635A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 09/29/2005 | CA2558372A1 Improved constructs for marker excision based on dual-function selection marker |
| 09/29/2005 | CA2558371A1 Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 09/29/2005 | CA2558273A1 Post harvest control of genetically modified crop growth employing d-amino acid compounds |
| 09/29/2005 | CA2558269A1 Sequence capable of accelerating gene expression at moderately low temperature |
| 09/29/2005 | CA2557836A1 Antisense composition and method for treating cancer |
| 09/29/2005 | CA2557476A1 Nitrile hydratases from metagenome libraries |